Molecular Cancer Therapeutics Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine Targeting the PI3-Kinase Pathway in Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gartel, A. L.
Right arrow Articles by Tyner, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gartel, A. L.
Right arrow Articles by Tyner, A. L.
Vol. 1, 639-649, June 2002     Molecular Cancer Therapeutics
© 2002 American Association for Cancer Research

Review

The Role of the Cyclin-dependent Kinase Inhibitor p21 in Apoptosis1

Andrei L. Gartel2 and Angela L. Tyner

Department of Molecular Genetics, University of Illinois College of Medicine, Chicago, Illinois 60607

Cancer develops when the balance between cell proliferation and cell death is disrupted, and the ensuing aberrant proliferation leads to tumor growth. The cyclin-dependent kinase inhibitor p21 is induced by both p53-dependent and -independent mechanisms following stress, and induction of p21 may cause cell cycle arrest. As a proliferation inhibitor, p21 is poised to play an important role in preventing tumor development. This notion is supported by data indicating that p21-null mice are more prone to spontaneous and induced tumorigenesis, and p21 synergizes with other tumor suppressors to protect against tumor progression in mice. However, a number of recent studies have pointed out that in addition to being an inhibitor of cell proliferation, p21 acts as an inhibitor of apoptosis in a number of systems, and this may counteract its tumor-suppressive functions as a growth inhibitor. In the current review, we discuss the role of p21 in regulating cell death and the potential relevance of its expression in cancer.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
R. Lazzarini, S. Moretti, S. Orecchia, P.-G. Betta, A. Procopio, and A. Catalano
Enhanced Antitumor Therapy by Inhibition of p21waf1 in Human Malignant Mesothelioma
Clin. Cancer Res., August 15, 2008; 14(16): 5099 - 5107.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. C. Crim, L. M. Sanders, M. Y. Hong, S. S. Taddeo, N. D. Turner, R. S. Chapkin, and J. R. Lupton
Upregulation of p21Waf1/Cip1 expression in vivo by butyrate administration can be chemoprotective or chemopromotive depending on the lipid component of the diet
Carcinogenesis, July 1, 2008; 29(7): 1415 - 1420.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
U. Murzik, P. Hemmerich, S. Weidtkamp-Peters, T. Ulbricht, W. Bussen, J. Hentschel, F. von Eggeling, and C. Melle
Rad54B Targeting to DNA Double-Strand Break Repair Sites Requires Complex Formation with S100A11
Mol. Biol. Cell, July 1, 2008; 19(7): 2926 - 2935.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Myrthue, B. L.S. Rademacher, J. Pittsenbarger, B. Kutyba-Brooks, M. Gantner, D. Z. Qian, and T. M. Beer
The Iroquois Homeobox Gene 5 Is Regulated by 1,25-Dihydroxyvitamin D3 in Human Prostate Cancer and Regulates Apoptosis and the Cell Cycle in LNCaP Prostate Cancer Cells
Clin. Cancer Res., June 1, 2008; 14(11): 3562 - 3570.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. M. Hawsawi, H. Ghebeh, S.-F. Hendrayani, A. Tulbah, M. Al-Eid, T. Al-Tweigeri, D. Ajarim, A. Alaiya, S. Dermime, and A. Aboussekhra
Breast Carcinoma-Associated Fibroblasts and Their Counterparts Display Neoplastic-Specific Changes
Cancer Res., April 15, 2008; 68(8): 2717 - 2725.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
P. Blancafort, M. P. Tschan, S. Bergquist, D. Guthy, A. Brachat, D. A. Sheeter, B. E. Torbett, D. Erdmann, and C. F. Barbas III
Modulation of drug resistance by artificial transcription factors
Mol. Cancer Ther., March 1, 2008; 7(3): 688 - 697.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Magenta, P. Fasanaro, S. Romani, V. Di Stefano, M. C. Capogrossi, and F. Martelli
Protein Phosphatase 2A Subunit PR70 Interacts with pRb and Mediates Its Dephosphorylation
Mol. Cell. Biol., January 15, 2008; 28(2): 873 - 882.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Fujiwara, S. Daido, A. Yamamoto, R. Kobayashi, T. Yokoyama, H. Aoki, E. Iwado, N. Shinojima, Y. Kondo, and S. Kondo
Pivotal Role of the Cyclin-dependent Kinase Inhibitor p21WAF1/CIP1 in Apoptosis and Autophagy
J. Biol. Chem., January 4, 2008; 283(1): 388 - 397.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Li, J. Tan, L. Zhuang, B. Banerjee, X. Yang, J. F. L. Chau, P. L. Lee, M. P. Hande, B. Li, and Q. Yu
Ribosomal Protein S27-like, a p53-Inducible Modulator of Cell Fate in Response to Genotoxic Stress
Cancer Res., December 1, 2007; 67(23): 11317 - 11326.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Brest, M. Gustafsson, A.-K. Mossberg, L. Gustafsson, C. Duringer, A. Hamiche, and C. Svanborg
Histone Deacetylase Inhibitors Promote the Tumoricidal Effect of HAMLET
Cancer Res., December 1, 2007; 67(23): 11327 - 11334.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Trent, C. Yang, C. Li, M. Lynch, and E. V. Schmidt
Heat Shock Protein B8, a Cyclin-Dependent Kinase Independent Cyclin D1 Target Gene, Contributes to Its Effects on Radiation Sensitivity
Cancer Res., November 15, 2007; 67(22): 10774 - 10781.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. M. Sankala, N. C. Hait, S. W. Paugh, D. Shida, S. Lepine, L. W. Elmore, P. Dent, S. Milstien, and S. Spiegel
Involvement of Sphingosine Kinase 2 in p53-Independent Induction of p21 by the Chemotherapeutic Drug Doxorubicin
Cancer Res., November 1, 2007; 67(21): 10466 - 10474.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Truffinet, E. Pinaud, N. Cogne, B. Petit, L. Guglielmi, M. Cogne, and Y. Denizot
The 3' IgH Locus Control Region Is Sufficient to Deregulate a c-myc Transgene and Promote Mature B Cell Malignancies with a Predominant Burkitt-Like Phenotype
J. Immunol., November 1, 2007; 179(9): 6033 - 6042.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C.-T. Chiang, T.-D. Way, and J.-K. Lin
Sensitizing HER2-overexpressing cancer cells to luteolin-induced apoptosis through suppressing p21WAF1/CIP1 expression with rapamycin
Mol. Cancer Ther., July 1, 2007; 6(7): 2127 - 2138.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Harms, K. Albrecht, U. Harms, K. Seidel, L. Hauck, T. Baldinger, D. Hubner, G. Kronenberg, J. An, K. Ruscher, et al.
Phosphatidylinositol 3-Akt-Kinase-Dependent Phosphorylation of p21Waf1/Cip1 as a Novel Mechanism of Neuroprotection by Glucocorticoids
J. Neurosci., April 25, 2007; 27(17): 4562 - 4571.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Aneja, A. M. Ghaleb, J. Zhou, V. W. Yang, and H. C. Joshi
p53 and p21 Determine the Sensitivity of Noscapine-Induced Apoptosis in Colon Cancer Cells
Cancer Res., April 15, 2007; 67(8): 3862 - 3870.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Kojima, M. Konopleva, I. J. Samudio, V. Ruvolo, and M. Andreeff
Mitogen-Activated Protein Kinase Kinase Inhibition Enhances Nuclear Proapoptotic Function of p53 in Acute Myelogenous Leukemia Cells
Cancer Res., April 1, 2007; 67(7): 3210 - 3219.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. F. Arias, A. Ballesteros-Tato, M. I. Garcia, J. Martin-Caballero, J. M. Flores, C. Martinez-A, and D. Balomenos
p21CIP1/WAF1 Controls Proliferation of Activated/Memory T Cells and Affects Homeostasis and Memory T Cell Responses
J. Immunol., February 15, 2007; 178(4): 2296 - 2306.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. P. Moiseeva, R. Heukers, and M. M. Manson
EGFR and Src are involved in indole-3-carbinol-induced death and cell cycle arrest of human breast cancer cells
Carcinogenesis, February 1, 2007; 28(2): 435 - 445.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. H. Patel and S. B. McMahon
BCL2 Is a Downstream Effector of MIZ-1 Essential for Blocking c-MYC-induced Apoptosis
J. Biol. Chem., January 5, 2007; 282(1): 5 - 13.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
S. Etemad-Moghadam, F. Baghaee, F. Tirgary, P. Motahhary, M. Khalili, N. Eshghyar, M. Alaedini, and M. Eslami
Expression of p21WAF in Salivary Gland Mucoepidermoid Carcinoma and Its Relation to Histologic Grade
International Journal of Surgical Pathology, January 1, 2007; 15(1): 6 - 13.
[Abstract] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Duan, J. Friedman, L. Nottingham, Z. Chen, G. Ara, and C. Van Waes
Nuclear factor-{kappa}B p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101
Mol. Cancer Ther., January 1, 2007; 6(1): 37 - 50.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S.-H. Juang, C.-C. Lung, P.-C. Hsu, K.-S. Hsu, Y.-C. Li, P.-C. Hong, H.-S. Shiah, C.-C. Kuo, C.-W. Huang, Y.-C. Wang, et al.
D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation
Mol. Cancer Ther., January 1, 2007; 6(1): 193 - 202.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. Y. Lim, Y. Jeong, A. L. Tyner, and J. H. Y. Park
Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin
Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G66 - G75.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Sohn, F. Essmann, K. Schulze-Osthoff, and R. U. Janicke
p21 Blocks Irradiation-Induced Apoptosis Downstream of Mitochondria by Inhibition of Cyclin-Dependent Kinase-Mediated Caspase-9 Activation
Cancer Res., December 1, 2006; 66(23): 11254 - 11262.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. Hever, R.B. Roth, P.A. Hevezi, J. Lee, D. Willhite, E.C. White, E.M. Marin, R. Herrera, H.M. Acosta, A.J. Acosta, et al.
Molecular characterization of human adenomyosis
Mol. Hum. Reprod., December 1, 2006; 12(12): 737 - 748.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. K. Ueda, H.-L. Lo, P. Bartolini, and A. M. Walker
S179D Prolactin Primarily Uses the Extrinsic Pathway and Mitogen-Activated Protein Kinase Signaling to Induce Apoptosis in Human Endothelial Cells
Endocrinology, October 1, 2006; 147(10): 4627 - 4637.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
R. P Singh and R. Agarwal
Mechanisms of action of novel agents for prostate cancer chemoprevention.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 751 - 778.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. M. Price, F. Yu, P. Kaldis, E. Aleem, G. Nowak, R. L. Safirstein, and J. Megyesi
Dependence of Cisplatin-Induced Cell Death In Vitro and In Vivo on Cyclin-Dependent Kinase 2
J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2434 - 2442.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Calcabrini, J. M. Garcia-Martinez, L. Gonzalez, M. J. Tendero, M. T. A. Ortuno, P. Crateri, A. Lopez-Rivas, G. Arancia, P. Gonzalez-Porque, and J. Martin-Perez
Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate
Carcinogenesis, August 1, 2006; 27(8): 1699 - 1712.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. L. Gartel
Is p21 an oncogene?
Mol. Cancer Ther., June 1, 2006; 5(6): 1385 - 1386.
[Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Gong, H. Sohn, L. Xue, G. L. Firestone, and L. F. Bjeldanes
3,3'-Diindolylmethane Is a Novel Mitochondrial H+-ATP Synthase Inhibitor that Can Induce p21Cip1/Waf1 Expression by Induction of Oxidative Stress in Human Breast Cancer Cells.
Cancer Res., May 1, 2006; 66(9): 4880 - 4887.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Kobayashi, T. Wang, M. Maezawa, M. Kobayashi, S. Ohnishi, K. Hatanaka, S. Hige, Y. Shimizu, M. Kato, M. Asaka, et al.
Overexpression of the Oncoprotein Prothymosin {alpha} Triggers a p53 Response that Involves p53 Acetylation.
Cancer Res., March 15, 2006; 66(6): 3137 - 3144.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. K. Radhakrishnan and A. L. Gartel
A novel transcriptional inhibitor induces apoptosis in tumor cells and exhibits antiangiogenic activity.
Cancer Res., March 15, 2006; 66(6): 3264 - 3270.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. Wood and A. Shilatifard
Transcriptional blackjack with p21.
Genes & Dev., March 15, 2006; 20(6): 643 - 647.
[Full Text] [PDF]


Home page
J. Nutr.Home page
R. Handayani, L. Rice, Y. Cui, T. A. Medrano, V. G. Samedi, H. V. Baker, N. J. Szabo, and K. T. Shiverick
Soy Isoflavones Alter Expression of Genes Associated with Cancer Progression, Including Interleukin-8, in Androgen-Independent PC-3 Human Prostate Cancer Cells
J. Nutr., January 1, 2006; 136(1): 75 - 82.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Juric, S. Sale, R. A. Hromas, R. Yu, Y. Wang, G. E. Duran, R. Tibshirani, L. H. Einhorn, and B. I. Sikic
Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures
PNAS, December 6, 2005; 102(49): 17763 - 17768.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Goulvestre, C. Chereau, C. Nicco, L. Mouthon, B. Weill, and F. Batteux
A Mimic of p21WAF1/CIP1 Ameliorates Murine Lupus
J. Immunol., November 15, 2005; 175(10): 6959 - 6967.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Wang, V. Devgan, M. Corrado, N. S. Prabhu, W. S. El-Deiry, C. Riccardi, P. P. Pandolfi, C. Missero, and G. P. Dotto
Glucocorticoid-induced Tumor Necrosis Factor Receptor Is a p21Cip1/WAF1 Transcriptional Target Conferring Resistance of Keratinocytes to UV Light-induced Apoptosis
J. Biol. Chem., November 11, 2005; 280(45): 37725 - 37731.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Barone, T. Okaya, S. Rudich, S. Petrovic, K. Tenrani, Z. Wang, K. Zahedi, R. A. Casero, A. B. Lentsch, and M. Soleimani
Distinct and sequential upregulation of genes regulating cell growth and cell cycle progression during hepatic ischemia-reperfusion injury
Am J Physiol Cell Physiol, October 1, 2005; 289(4): C826 - C835.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-V. Le, A. J. Minn, and J. Massague
Cyclin-dependent Kinase Inhibitors Uncouple Cell Cycle Progression from Mitochondrial Apoptotic Functions in DNA-damaged Cancer Cells
J. Biol. Chem., September 9, 2005; 280(36): 32018 - 32025.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Yang, S. G. Carlson, D. McBurney, and W. E. Horton Jr.
Multiple Signals Induce Endoplasmic Reticulum Stress in Both Primary and Immortalized Chondrocytes Resulting in Loss of Differentiation, Impaired Cell Growth, and Apoptosis
J. Biol. Chem., September 2, 2005; 280(35): 31156 - 31165.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. A. Nath
Provenance of the protective property of p21
Am J Physiol Renal Physiol, September 1, 2005; 289(3): F512 - F513.
[Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Rodriguez-Vilarrupla, M. Jaumot, N. Abella, N. Canela, S. Brun, C. Diaz, J. M. Estanyol, O. Bachs, and N. Agell
Binding of Calmodulin to the Carboxy-Terminal Region of p21 Induces Nuclear Accumulation via Inhibition of Protein Kinase C-Mediated Phosphorylation of Ser153
Mol. Cell. Biol., August 15, 2005; 25(16): 7364 - 7374.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Tajeddine, J.-L. Gala, M. Louis, M. Van Schoor, B. Tombal, and P. Gailly
Tumor-Associated Antigen Preferentially Expressed Antigen of Melanoma (PRAME) Induces Caspase-Independent Cell Death In vitro and Reduces Tumorigenicity In vivo
Cancer Res., August 15, 2005; 65(16): 7348 - 7355.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Weinberger, L. Ramachandran, L. Feng, K. Sharma, X. Sun, M. Marchetti, J. A. Huberman, and W. C. Burhans
Apoptosis in budding yeast caused by defects in initiation of DNA replication
J. Cell Sci., August 1, 2005; 118(15): 3543 - 3553.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. L. Collins, M. J. Reginato, J. K. Paulus, D. C. Sgroi, J. LaBaer, and J. S. Brugge
G1/S Cell Cycle Arrest Provides Anoikis Resistance through Erk-Mediated Bim Suppression
Mol. Cell. Biol., June 15, 2005; 25(12): 5282 - 5291.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Erker, R. Schubert, H. Yakushiji, C. Barlow, D. Larson, J. B. Mitchell, and A. Wynshaw-Boris
Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor
Hum. Mol. Genet., June 15, 2005; 14(12): 1699 - 1708.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. M. Wuerzberger-Davis, P.-Y. Chang, C. Berchtold, and S. Miyamoto
Enhanced G2-M Arrest by Nuclear Factor-{kappa}B-Dependent p21waf1/cip1 Induction
Mol. Cancer Res., June 1, 2005; 3(6): 345 - 353.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. L. Gartel and S. K. Radhakrishnan
Lost in Transcription: p21 Repression, Mechanisms, and Consequences
Cancer Res., May 15, 2005; 65(10): 3980 - 3985.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. A. Jessen, N. M. English, J. Yu Wang, S. Maliartchouk, S. P. Archer, L. Qiu, R. Brand, J. Kuemmerle, H.-Z. Zhang, K. Gehlsen, et al.
The discovery and mechanism of action of novel tumor-selective and apoptosis-inducing 3,5-diaryl-1,2,4-oxadiazole series using a chemical genetics approach
Mol. Cancer Ther., May 1, 2005; 4(5): 761 - 771.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. P. Trivedi, P. C. Roberts, N. A. Wolf, and R. H. Swanborg
NK Cells Inhibit T Cell Proliferation via p21-Mediated Cell Cycle Arrest
J. Immunol., April 15, 2005; 174(8): 4590 - 4597.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Robitaille, R. Proulx, K. Robitaille, R. Blouin, and L. Germain
The Mitogen-activated Protein Kinase Kinase Kinase Dual Leucine Zipper-bearing Kinase (DLK) Acts as a Key Regulator of Keratinocyte Terminal Differentiation
J. Biol. Chem., April 1, 2005; 280(13): 12732 - 12741.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
K. J. Liu and R. M. Harland
Inhibition of neurogenesis by SRp38, a neuroD-regulated RNA-binding protein
Development, April 1, 2005; 132(7): 1511 - 1523.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Kontopidis, S.-Y. Wu, D. I. Zheleva, P. Taylor, C. McInnes, D. P. Lane, P. M. Fischer, and M. D. Walkinshaw
From the Cover: Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design
PNAS, February 8, 2005; 102(6): 1871 - 1876.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Dong, Q. Li, S.-c. Lyu, A. M. Krensky, and C. Clayberger
A novel apoptosis pathway activated by the carboxyl terminus of p21
Blood, February 1, 2005; 105(3): 1187 - 1194.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. J. Merched and L. Chan
Absence of p21Waf1/Cip1/Sdi1 Modulates Macrophage Differentiation and Inflammatory Response and Protects Against Atherosclerosis
Circulation, December 21, 2004; 110(25): 3830 - 3841.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Amini, M. Saunders, K. Kelley, K. Khalili, and B. E. Sawaya
Interplay between HIV-1 Vpr and Sp1 Modulates p21WAF1 Gene Expression in Human Astrocytes
J. Biol. Chem., October 29, 2004; 279(44): 46046 - 46056.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. R. Boverhof, K. C. Fertuck, L. D. Burgoon, J. E. Eckel, C. Gennings, and T. R. Zacharewski
Temporal- and dose-dependent hepatic gene expression changes in immature ovariectomized mice following exposure to ethynyl estradiol
Carcinogenesis, July 1, 2004; 25(7): 1277 - 1291.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Deguchi, W. J. Thompson, and I. B. Weinstein
Activation of Protein Kinase G Is Sufficient to Induce Apoptosis and Inhibit Cell Migration in Colon Cancer Cells
Cancer Res., June 1, 2004; 64(11): 3966 - 3973.
[Abstract] [Full Text] [PDF]


Home page